National Human Genome Research Institute; Notice of Closed Meetings, 32761 [2016-12139]
Download as PDF
<![CDATA[
32761
Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total
burden
hours
Corps Community Month Event Planning Form ..................
Corps Community Month Event Satisfaction .......................
300
300
1
1
300
300
.066
.033
19.8
9.9
Total ..............................................................................
* 300
........................
* 300
........................
29.7
* The same individuals complete both of the forms for a total of 300 respondents and responses.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2016–12146 Filed 5–23–16; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
sradovich on DSK3TPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Gabriella Miller Kids First Sequencing
Center.
Date: June 14, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NHGRI, 5635FL, Twinbrook 4th
Floor Conf. Rm., Twinbrook, Rockville, MD
20852 (Telephone Conference Call).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; ENCODE MAPPING.
Date: June 21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Dulles Airport Marriott,
45020, Dulles View, Aviation Drive, Dulles,
VA 20166.
VerDate Sep<11>2014
17:24 May 23, 2016
Jkt 238001
Contact Person: Ken D. Nakamura, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Suite 4076, MSC 9306,
Rockville, MD 20852, 301–402–0838,
nakamurk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS).
Dated: May 17, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–12139 Filed 5–23–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive Patent
License: Development of AdenoAssociated Virus Vectors for the
Treatment of Glycogen Storage
Disease Type Ia
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health, Department of
Health and Human Services (HHS), is
contemplating the grant of an exclusive
license to practice the inventions
embodied in the following Patent
Applications to Dimension
Therapeutics, Inc. (‘‘Dimension’’)
located in Cambridge, Massachusetts,
USA:
SUMMARY:
Intellectual Property
United States Provisional Patent
Application No. 61/908,861, filed
November 26, 2013, titled ‘‘AdenoAssociated Virus Vectors for the
Treatment of Glycogen Storage Disease’’
[HHS Reference No. E–552–2013/0–US–
01]; International Patent Application
No. PCT/US2014/067415 filed
November 25, 2014 titled ‘‘AdenoAssociated Virus Vectors for the
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Treatment of Glycogen Storage Disease’’
[HHS Reference No. E–552–2013/0–
PCT–02] and continuation applications,
divisional applications and foreign
counterpart applications claiming
priority to the US provisional
application No. 61/908,861.
With respect to persons who have an
obligation to assign their right, title and
interest to the Government of the United
States of America, the patent rights in
these inventions have been assigned to
the Government of the United States of
America.
The prospective exclusive licensed
territory may be worldwide and the
field of use may be limited to:
‘‘Development and commercialization of
gene therapy using adeno-associated
viral vectors for the treatment of
Glycogen Storage Disease Type Ia.’’
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before June
8, 2016 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, comments,
and other materials relating to the
contemplated exclusive license should
be directed to: Surekha Vathyam, Ph.D.,
Senior Licensing and Patenting
Manager, National Cancer Institute
Technology Transfer Center, 9609
Medical Center Drive, Rm. 1E–530,
MSC9702, Rockville, MD 20850–9702,
Email: vathyams@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
subject technologies disclose novel
adeno-associated virus (AAV) vectors
expressing human glucose-6phosphatase-alpha (G6Pase-alpha or
G6PC) for the treatment of glycogen
storage disease, particularly glycogen
storage disease type Ia (GSD-Ia). GSD-Ia
is an inherited disorder of metabolism
associated with life-threatening
hypoglycemia, hepatic malignancy, and
renal failure caused by the deficiency of
G6Pase-alpha, a key enzyme in
maintaining blood glucose homeostasis
between meals. The two novel gene
therapy vectors of the invention, rAAVGPE-G6PC and rAAV-GPE-co-G6PC are
recombinant AAV vectors expressing
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Page 32761]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12139]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; Gabriella Miller Kids First Sequencing
Center.
Date: June 14, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: NHGRI, 5635FL, Twinbrook 4th Floor Conf. Rm., Twinbrook,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD
20852, (301) 402-0838, pozzattr@mail.nih.gov.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; ENCODE MAPPING.
Date: June 21, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Dulles Airport Marriott, 45020, Dulles View,
Aviation Drive, Dulles, VA 20166.
Contact Person: Ken D. Nakamura, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, National Institutes of Health, 5635 Fishers Lane, Suite
4076, MSC 9306, Rockville, MD 20852, 301-402-0838,
nakamurk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS).
Dated: May 17, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-12139 Filed 5-23-16; 8:45 am]
BILLING CODE 4140-01-P
